- University of Pennsylvania (B.A., 1987, summa cum laude)
- Yale Law School (J.D.,1990, Coker Fellow)
- District of Columbia
- United States Supreme Court
- United States District Court for the District of Colorado, and the District of Columbia
- United States Court of Appeals for the Fourth, Fifth, Sixth, Seventh, Eighth, Tenth, and District of Columbia Circuits
- Law360: D.C. Circ. Won't Reconsider DynCorp's Win In Chemical Suit
- Hollingsworth LLP files amici brief in support of federal jurisdiction for out-of-state defendants
- Fifth Circuit Puts an End to Texas Pharma Plaintiff’s California Dreamin’
- Forbes on DynCorp victory in D.C. Circuit: "Ecuador Bites the Dust ...Again"
- Hollingsworth LLP hosts its 26th Annual Seminar on Complex Litgation Defense, at the U.S. Chamber of Commerce
- view all
- Texas Supreme Court Rejects "Any Exposure" Causation in Asbestos Litigation
- "The quest for the next ‘solvent bystander’ in asbestos litigation: Will Texas resume the search?"
- Hollingsworth LLP submits coalition amicus brief in the Texas Supreme Court, in support of "but for" causation requirement in asbestos mesothelioma litigation.
- "Prescription Drug Products Liability Litigation and Punitive Damages Preemption "
- "Preemption of Punitive Damages in Prescription Drug Litigation"
- view all
- Wilson v. Novartis Pharm. Corp., __ F. App’x __, No. 13-10309, 2014 WL 3378316 (5th Cir. July 11, 2014)
- Arias v. DynCorp, ___ F.3d ___, 2014 WL 2219109 (D.C. Cir. May 30, 2014)
- McKay v. Novartis Pharm. Corp., No. 13-50404 (5th Cir. May 27, 2014)
- Irby v. Novartis Pharm. Corp., No. A-4871-11T3 (N.J. Super. Ct. App. Div. June 14, 2013)
- Guenther v. Novartis Pharm. Corp., No. 6:08-cv-00456-GAP-DAB (M.D. Fla. Mar. 26, 2013)
- Arias, et al. v. DynCorp, et al., 928 F. Supp.2d 10, 2013 WL 821168 (D.D.C. Feb. 19, 2013)
- Arias, et al. v. DynCorp, et al., 928 F. Supp.2d 1, 2013 WL 864566 (D.D.C. Feb. 6, 2013)
- Sherwin-Williams Co. v. Gaines, No. 2009-CA-01866-SCT (Miss. Sept. 8, 2011) (Hollingsworth LLP participated as amicus).
- Patterson v. Novartis Pharm. Corp., No. 10-5886, 2011 WL 3701884 (6th Cir. Aug. 23, 2011).
- Arias, et. al., v. DynCorp, et., al., 738 F. Supp.2d 46 (D.D.C. Sept. 15, 2010)
- Frey v. Novartis Pharms. Corp., No. C-1-07-317 (S.D. Ohio July 23, 2009).
- Rhode Island v. Lead Indus. Ass'n, Inc., PC 99-5226 (R.I. July 1, 2008) (Hollingsworth LLP participated as amicus).
- Thompson v. Novartis Pharms. Corp., No. 07CV1533 (Dist. Ct. Colo. Jan. 15, 2008) (order granting Motion to Sever).
- Georgia-Pacific Corp. v. Stephens, No. 01-05-00132 (Tex. Ct. App. July 7, 2007).
- Waldon v. Novartis Pharms. Corp., No. C07-01988 MJJ (N.D. Cal. June 18, 2007).
- City of St. Louis v. Benjamin Moore & Co., ___ S.W.3d ___, No. SC 88230, 2007 WL 1693582 (Mo. June 12, 2007) (Hollingsworth LLP participated as amicus).
- Quinteros v. DynCorp Aerospace Operations LLC, No. 06-61760 (S.D. Fla. May 23, 2007).
- New Mexico v. Gen. Elec. Co., 467 F.3d 1223 (10th Cir. 2006)
- New Mexico v. Gen. Elec. Co., 322 F. Supp. 2d 1237 (D.N.M. 2004).
- New Mexico v. Gen. Elec. Co., 335 F. Supp. 2d 1266 (D.N.M. 2004).
- New Mexico v. Gen. Elec. Co., 335 F. Supp. 2d 1185 (D.N.M. 2004).
- New Mexico v. Gen. Elec. Co., 335 F. Supp. 2d 1157 (D.N.M. 2003).
- Firm partners Eric Lasker and Richard Faulk to speak at Eighth Annual Judicial Symposium
- Firm partner Eric Lasker moderates panel presentation on Daubert: The Next 20 Years
- Firm Partner Eric Lasker presents at Second Annual Advanced Seminar on Natural Resource Damages, February 14-15, in Washington, DC.
- Firm Partner Eric Lasker Presents on Preemption of GMO Food Labeling Laws for Washington Legal Foundation
- Firm Partner Eric Lasker moderates expert panel on new Scientific Reference Guide.
- Eric Lasker moderates panel "Defending Multinational Corporations In an International Legal Marketplace" at the 2012 Midyear Meeting of the International Association of Defense Counsel.
- Firm Partner Eric Lasker to present at LSI Natural Resource Damages Seminar in January.
- The American Coatings Association invites Firm partners Eric Lasker and Kirby Griffis to present at the Annual Fall meeting of its Corporate Counsels Advisory Group.
- Partners Joe Hollingsworth and Eric Lasker to speak at the Mason Judicial Education Program’s Sixth Annual Judicial Symposium on Civil Justice in November.
- For the second consecutive year, firm partner Eric Lasker to serve on expert panel at national conference of medical device manufacturers.
- International Association of Defense Counsel invites Eric Lasker to serve on two speaker panels at its 2011 MidYear meeting.
- Firm partner Eric Lasker to speak January 20-21 in Miami, FL at Law Seminars International's advanced conference on Natural Resource Damages: The Ground, Groundwater and The Gulf.
- Law Seminars International to hold sixth annual conference on Natural Resource Damages Litigation, Nov. 15-16, 2010; partner Eric Lasker will present.
- Firm partner Eric Lasker to serve on Legal/IP Peer Review Panel for AdvaMed 2010 Conference.
- Firm partner Eric Lasker speaks at the June 2010 HB Litigation Conference's Oil in the Gulf-Litigation and Insurance Coverage Conference.
- Partner Eric Lasker presents at LSI's 5th annual conference on Natural Resource Damages Litigation.
- Firm partner Eric Lasker serves on expert panel on FDA preemption at national conference of medical device manufacturers.
- Eric Lasker presents "Strategically Developing and Litigating the Preemption Defense" at ACI's "Drug & Device Preemption: Eliminating product liability claims on the wholesale level in an evolving legal landscape."
- Eric Lasker presents at Spring Meeting of Manufacturer Alliance/MAPI's Product Liability and Product Safety Council.
- Partner Eric Lasker to present at LSI's 3rd annual conference on Natural Resource Damages Litigation.
- Partner Eric Lasker presents at WLF Web Seminar Series on Proposition 65
- Preemption Argument Takes Center Stage During Mealey's SSRI Teleconference.
- Eric Lasker to serve on natural resource damages panel at the 2004 Fall meeting of the ABA Section of Environment, Energy, and Resources.
Mr. Lasker litigates a wide variety of complex civil matters, with a current focus on toxic torts, environmental litigation, Alien Tort Statute litigation, and pharmaceutical products liability. He has successfully represented his clients' interests as lead counsel in jury trials and bench proceedings and in oral argument in multiple federal courts of appeal. In 2013, Mr. Lasker was named by Law360 as one of its five national Products Liability MVPs.
Mr. Lasker was recognized by The American Lawyer as "Litigator of the Week" and featured on the Bloomberg News program "Rainmakers" for his work in securing a victory for Firm client, DynCorp International. In 2013, the U.S. District Court for the District of Columbia granted summary judgment to DynCorp, dismissing the sole remaining human health and medical monitoring claims brought by 3,200 Ecuadorans claiming personal injury and property damage in connection with counternarcotics aerial herbicide spraying operations in southern Colombia. DynCorp is a contractor to the U.S. Department of State and assists with the joint United States-Colombia war-on-drugs initiatives known as “Plan Colombia.” See Arias, et al. v. DynCorp, et al., 928 F.Supp.2d 10, 2013 WL 821168 (D.D.C. Feb. 19, 2013). Mr. Lasker subsequently defended those victories before the U.S. Court of Appeals for the D.C. Circuit. See Arias v. DynCorp, ___ F.3d ___, 2014 WL 2219109 (D.C. Cir. May 30, 2014).
Mr. Lasker has significant experience defending against all matter of legal claims involving FDA-regulated and EPA-regulated products and alleged toxins and environmental contaminants. He has represented clients in pharmaceutical products liability claims involving antipsychotic medications, obstetrical drugs, antifungals, antiepileptics, contact and intraocular lenses, and cough/cold medicines, and in toxics/environmental matters involving herbicides, asbestos, lead paint, nonionizing radiation, and chemical solvents. He has represented clients in matters arising both in the United States and abroad, and in matters arising under both domestic and international law. Mr. Lasker's practice also includes matters involving sensitive national security issues, and he has represented his clients’ interests in meetings with both U.S. and foreign government officials. He has extensive expertise in developing and implementing sophisticated medical causation and science-based defenses, and he has successfully litigated issues involving Daubert, the federal preemption defense, and natural resource damages claims. See New Mexico v. General Electric, 467 F.3d 1223 (10th Cir. 2006). He also assists clients in due diligence investigations as relates to environmental and toxics liabilities and through an active amicus practice on behalf of various industry organizations, including the United States Chamber of Commerce, the National Association of Manufacturers, the American Chemistry Council, the American Coatings Association, and the Washington Legal Foundation, among others.
Mr. Lasker played a prominent role in helping to establish asbestos defendants’ rights to insurance non-products coverage through a successful amicus effort that secured one of the seminal judicial opinions recognizing the existence of such coverage, litigation efforts resulting in securing several hundreds of millions of dollars in asbestos non-products insurance recoveries, and oral presentations and publications on issues involving non-products coverage. He has also defended personal injury claims in asbestos litigation, advancing medical causation defenses as the asbestos litigation has extended to tertiary and even more remotely-situated corporate defendants.
Mr. Lasker is frequently requested to speak and publish on issues of interest to his clients. He is the recipient of the 2012 George Yancey Memorial Award and the 2014 Burton Award for excellence in legal writing.
Mr. Lasker currently serves on the CLE Committee of the International Association of Defense Counsel's (IADC), which has responsibility over all CLE programming at IADC's midyear and annual meetings as well as oversight of CLE programming at its Corporate Counsel College and International Corporate Counsel College. He previously served as the Chair of the IADC Toxics & Hazardous Substances Committee and on the Board of Editors of LJN's Product Liability Law & Strategy newsletter. He is a member of the Defense Research Institute (DRI).
Mr. Lasker is named in the 2014 Washington, DC edition of Super Lawyers, and listed as a Top Rated Lawyer™ by American Lawyer Media & Martindale-Hubbell™.